Latest stories on PBM
Psyence BioMed raises its PsyLabs stake to 43.37% after ibogaine milestones trigger a $2.60 million backstop investment
October 21, 2026
MarketChameleon63 · neutralgeneral
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
Business Insider63 · neutralproduct/pr
PBM Targets U.S. Pharmaceutical-Grade Ibogaine Manufacturing Through a DEA-Registered 83,000-Sq.-Ft. Texas Facility
MarketChameleon67 · bullishproduct/pr
Psyence Biomedical teams with Benuvia to establish U.S. manufacture of ibogaine
The Fly56 · neutralproduct/pr
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
GlobeNewswire63 · neutralproduct/pr
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
Business Insider63 · neutralproduct/pr
Psychedelic: Psyence BioMed announces exclusive U.S. ibogaine license
The Fly63 · neutralgeneral
Psyence Biomedical announces exclusive U.S. Ibogaine license for TIRC
The Fly59 · neutralgeneral
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
StockTitan59 · neutralgeneral
Psyence BioMed Agrees Up to $5 Million PsyLabs Investment and Forms Texas Ibogaine Unit
InvestorsHub58 · neutralgeneral
Psyence BioMed targets a Texas ibogaine trial with a US$5 million PsyLabs investment and a US$9 million share swap
September 23, 2026
MarketChameleon58 · neutralgeneral
Psyence Biomedical announces strategic Ibogaine investment
The Fly56 · neutralproduct/pr
Psyence BioMed Announces Strategic Ibogaine Investment
Business Insider58 · neutralproduct/pr
Psyence Biomedical establishes Texas Ibogaine Research Corporation
The Fly55 · neutralgeneral
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
StockTitan63 · neutralproduct/pr
Psyence Biomedical files to sell 1.15M common shares for holders
The Fly28 · bearishgeneral
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
StockTitan63 · neutralproduct/pr
Psyence Biomedical stock surges on Trump ibogaine announcement
Investing.com Markets63 · neutralgeneral
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update
TipRanks56 · neutralproduct/pr
PitchBook and Madrona to Talk AI and Capital Concentration at Seattle Tech Week
StockTitan56 · neutralproduct/pr